Header Logo

Parameswaran Venugopal

Concepts (175)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.


Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Antineoplastic Combined Chemotherapy Protocols
9
2021
105
0.750
Why?
Lymphoma, Non-Hodgkin
5
2019
20
0.710
Why?
Arabinonucleosides
2
2021
4
0.500
Why?
Antineoplastic Agents
4
2022
99
0.500
Why?
Antibodies, Monoclonal, Murine-Derived
6
2017
15
0.470
Why?
Lymphoma, Large B-Cell, Diffuse
3
2017
24
0.340
Why?
Burkitt Lymphoma
2
2021
5
0.340
Why?
Adenine Nucleotides
1
2010
1
0.330
Why?
Antibodies, Monoclonal
3
2008
86
0.320
Why?
Arsenicals
2
2007
6
0.310
Why?
Oxides
2
2007
7
0.310
Why?
Cranial Irradiation
2
2007
6
0.310
Why?
Humans
24
2022
12240
0.290
Why?
Lymphohistiocytosis, Hemophagocytic
1
2008
7
0.280
Why?
Middle Aged
14
2022
4043
0.280
Why?
Cachexia
2
2019
8
0.270
Why?
Rituximab
7
2021
19
0.260
Why?
Leukemia, Myelomonocytic, Acute
1
2007
1
0.260
Why?
Ear Neoplasms
1
2007
3
0.260
Why?
Sarcoma, Myeloid
1
2007
4
0.250
Why?
Male
14
2022
6815
0.250
Why?
Adult
10
2021
3557
0.230
Why?
Female
14
2021
6974
0.220
Why?
Immunotherapy
2
2008
27
0.220
Why?
Lymphomatoid Granulomatosis
1
2003
2
0.200
Why?
Brain Neoplasms
1
2003
35
0.200
Why?
Lymphoma, B-Cell
3
2008
7
0.200
Why?
Disease-Free Survival
4
2021
66
0.190
Why?
Leukemia, Lymphocytic, Chronic, B-Cell
1
2022
6
0.180
Why?
Aged
9
2021
4000
0.180
Why?
Leukemia, Myeloid, Acute
1
2021
20
0.170
Why?
Central Nervous System Neoplasms
1
2021
6
0.170
Why?
Drug Resistance, Neoplasm
3
2020
42
0.170
Why?
Thrombosis
1
2021
33
0.170
Why?
Aged, 80 and over
5
2021
2152
0.170
Why?
Cyclophosphamide
5
2021
22
0.160
Why?
Deubiquitinating Enzymes
1
2020
1
0.160
Why?
Benzylidene Compounds
1
2020
1
0.160
Why?
Azepines
1
2020
2
0.160
Why?
Multiple Myeloma
1
2020
7
0.160
Why?
Graft vs Host Disease
1
2020
31
0.150
Why?
Respiratory Insufficiency
1
2020
34
0.150
Why?
Phthalazines
1
2019
4
0.150
Why?
Folic Acid Deficiency
1
2019
6
0.150
Why?
Hematopoietic Stem Cell Transplantation
1
2020
57
0.150
Why?
Treatment Outcome
8
2021
1478
0.150
Why?
Paraproteinemias
1
2019
2
0.150
Why?
Piperazines
1
2019
41
0.140
Why?
Doxorubicin
4
2021
34
0.140
Why?
Kidney Diseases
1
2019
31
0.140
Why?
Remission Induction
4
2007
45
0.140
Why?
HIV Infections
1
2021
256
0.140
Why?
Medical Oncology
1
2018
23
0.140
Why?
Cardiology
1
2018
26
0.140
Why?
Vincristine
4
2017
15
0.120
Why?
Recurrence
2
2020
126
0.120
Why?
Prednisone
4
2017
31
0.120
Why?
Prognosis
4
2021
363
0.110
Why?
Hematologic Neoplasms
1
2014
8
0.110
Why?
Neoplasm Recurrence, Local
2
2021
69
0.100
Why?
Metabolic Syndrome
1
2014
40
0.100
Why?
Diabetes Mellitus, Type 2
1
2014
82
0.100
Why?
Obesity
1
2014
156
0.100
Why?
Hemoglobinuria, Paroxysmal
1
2012
1
0.090
Why?
Fatal Outcome
2
2008
28
0.090
Why?
Combined Modality Therapy
2
2019
143
0.080
Why?
Retreatment
1
2010
3
0.080
Why?
Salvage Therapy
1
2010
7
0.080
Why?
Granulocyte-Macrophage Colony-Stimulating Factor
1
2008
10
0.070
Why?
Severity of Illness Index
2
2021
423
0.070
Why?
Weight Loss
2
2019
78
0.070
Why?
Cohort Studies
2
2021
827
0.070
Why?
Daunorubicin
1
2007
3
0.060
Why?
Tretinoin
1
2007
8
0.060
Why?
Injections, Spinal
1
2007
16
0.060
Why?
Lymphoproliferative Disorders
1
2006
8
0.060
Why?
Young Adult
2
2021
863
0.060
Why?
Radiography
1
2007
258
0.060
Why?
Kidney Transplantation
1
2006
51
0.060
Why?
Kaplan-Meier Estimate
2
2021
85
0.050
Why?
Proto-Oncogenes
1
2004
3
0.050
Why?
Thalidomide
1
2004
3
0.050
Why?
Myelodysplastic Syndromes
1
2004
10
0.050
Why?
Peripheral Blood Stem Cell Transplantation
1
2004
1
0.050
Why?
Transcription Factors
1
2004
105
0.050
Why?
Antigens, CD20
1
2003
4
0.050
Why?
Epilepsy, Tonic-Clonic
1
2003
3
0.050
Why?
Herpesvirus 4, Human
1
2003
3
0.050
Why?
Epstein-Barr Virus Infections
1
2003
5
0.050
Why?
Vision Disorders
1
2003
8
0.050
Why?
Antigens, Neoplasm
1
2003
22
0.050
Why?
Methotrexate
1
2003
18
0.050
Why?
DNA-Binding Proteins
1
2004
151
0.050
Why?
Telomerase
1
2003
2
0.050
Why?
K562 Cells
1
2003
4
0.050
Why?
Histones
1
2003
13
0.050
Why?
Postoperative Complications
1
2006
385
0.050
Why?
Retrospective Studies
2
2019
1467
0.050
Why?
Cerebral Cortex
1
2003
77
0.050
Why?
Bridged Bicyclo Compounds, Heterocyclic
1
2022
1
0.050
Why?
Voriconazole
1
2022
7
0.040
Why?
Sulfonamides
1
2022
22
0.040
Why?
Cytosine
1
2021
2
0.040
Why?
Azacitidine
1
2021
9
0.040
Why?
Magnetic Resonance Imaging
1
2003
464
0.040
Why?
Central Nervous System
1
2021
29
0.040
Why?
L-Lactate Dehydrogenase
1
2021
3
0.040
Why?
Lung Neoplasms
1
2003
247
0.040
Why?
Gene Rearrangement
1
2021
5
0.040
Why?
Proto-Oncogene Proteins c-myc
1
2021
8
0.040
Why?
Infusions, Intravenous
1
2020
31
0.040
Why?
Transplantation, Homologous
1
2020
93
0.040
Why?
Folic Acid
1
2019
15
0.040
Why?
Monoclonal Gammopathy of Undetermined Significance
1
2019
2
0.040
Why?
Immunoglobulin A
1
2019
4
0.040
Why?
Kidney Function Tests
1
2019
10
0.040
Why?
Symptom Assessment
1
2019
10
0.040
Why?
Sarcopenia
1
2019
15
0.040
Why?
Survival Analysis
1
2019
99
0.040
Why?
Ovarian Neoplasms
1
2019
36
0.040
Why?
Body Composition
1
2019
43
0.040
Why?
Biopsy
1
2019
97
0.040
Why?
Disease Management
1
2019
59
0.040
Why?
Interdisciplinary Communication
1
2018
9
0.030
Why?
Cardiologists
1
2018
2
0.030
Why?
Sex Factors
1
2019
229
0.030
Why?
Adolescent
1
2021
989
0.030
Why?
Neoplasms
1
2019
94
0.030
Why?
Bortezomib
1
2017
3
0.030
Why?
United States
1
2021
989
0.030
Why?
Biomarkers
1
2019
294
0.030
Why?
Proportional Hazards Models
1
2017
161
0.030
Why?
Recombinant Proteins
2
2008
90
0.030
Why?
Lipid Metabolism
1
2014
23
0.030
Why?
Insulin Resistance
1
2014
19
0.030
Why?
Signal Transduction
1
2014
246
0.020
Why?
Animals
1
2014
2092
0.020
Why?
Platelet Count
1
2007
6
0.020
Why?
Cytarabine
1
2007
5
0.020
Why?
Etoposide
1
2007
15
0.020
Why?
Neutropenia
1
2007
8
0.020
Why?
Nausea
1
2007
16
0.020
Why?
Creatinine
1
2007
29
0.020
Why?
Methylprednisolone
1
2007
10
0.020
Why?
Thrombocytopenia
1
2007
12
0.020
Why?
Anemia
1
2007
15
0.020
Why?
Cisplatin
1
2007
25
0.020
Why?
Tomography, Emission-Computed
1
2006
5
0.020
Why?
Sensitivity and Specificity
1
2006
252
0.010
Why?
MDS1 and EVI1 Complex Locus Protein
1
2004
2
0.010
Why?
Cell Lineage
1
2004
13
0.010
Why?
Zinc Fingers
1
2004
10
0.010
Why?
Spleen
1
2004
15
0.010
Why?
Prospective Studies
1
2007
817
0.010
Why?
Reverse Transcriptase Polymerase Chain Reaction
1
2004
68
0.010
Why?
Drug Therapy, Combination
1
2004
76
0.010
Why?
Bleomycin
1
2004
1
0.010
Why?
Teniposide
1
2004
1
0.010
Why?
Mitoxantrone
1
2004
2
0.010
Why?
Leukopenia
1
2004
4
0.010
Why?
Lymphoma, Follicular
1
2004
2
0.010
Why?
Interferon-alpha
1
2004
15
0.010
Why?
Transplantation, Autologous
1
2004
42
0.010
Why?
Immunosuppressive Agents
1
2004
61
0.010
Why?
Drug Administration Schedule
1
2004
84
0.010
Why?
Karyotyping
1
2003
7
0.010
Why?
Granulocytes
1
2003
6
0.010
Why?
In Situ Hybridization, Fluorescence
1
2003
12
0.010
Why?
DNA Primers
1
2003
30
0.010
Why?
Polymerase Chain Reaction
1
2003
57
0.010
Why?
Disease Progression
1
2004
290
0.010
Why?
Bone Marrow
1
2003
35
0.010
Why?
Acute Disease
1
2003
90
0.010
Why?
RNA, Messenger
1
2003
157
0.010
Why?
Risk Factors
1
2004
1049
0.010
Why?
Venugopal's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (175)
Explore
_
Co-Authors (17)
Explore
_
Similar People (60)
Explore
_
Same Department Expand Description
Explore
_